SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193805-24-000129
Filing Date
2024-02-05
Accepted
2024-02-05 08:30:32
Documents
4
Period of Report
2024-03-04

Document Format Files

Seq Description Document Type Size
1 e619216_def14a-immunic.htm DEF 14A 657242
2 GRAPHIC image_001.jpg GRAPHIC 631
3 GRAPHIC image_002.jpg GRAPHIC 6573
4 GRAPHIC image_003.jpg GRAPHIC 4798
  Complete submission text file 0001193805-24-000129.txt   675368
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36201 | Film No.: 24594145
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)